Home
Conditions
Severe Combined Immunodeficiency

Clinical trial condition

Severe Combined Immunodeficiency

Explore clinical trials studying Severe Combined Immunodeficiency. Study availability and eligibility vary by location and protocol.

43 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Severe Combined Immunodeficiency trial results

Completed

Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant

NCT00008450

Conditions: Adenosine Deaminase Deficiency, Autosomal Recessive Disorder, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +17 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Generalized Neonatal Screening of Severe Combined Immunodeficiencies

NCT02244450

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +9 more
Locations: Angers Private Hospital Clinique de l'Anjou Angers, France

Angers University Hospital Angers, France

Argenteuil Hospital Argenteuil, France

Aulnay-sous-Bois Hospital CHI Robert Ballanger Aulnay-sous-Bois, France

View all 51 locations

View Trial Details

Completed

Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)

NCT00028236

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Influences on Female Adolescents' Decisions Regarding Testing for Carrier Status of XSCID

NCT00006335

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Developing Newborn Screening for Infants With Primary Immunodeficiency

NCT00113464

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +9 more
Locations: Yale University New Haven, Connecticut, United States

View Trial Details

Completed

Cord Blood Stem Cell Transplantation Study (COBLT)

NCT00000603

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +21 more
Locations: Not specified

View Trial Details

Completed

Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders

NCT00744692

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +43 more
Locations: Duke University Medical Center Pediatric Blood and Marrow Transplant Program Durham, North Carolina, United States

View Trial Details

Completed

Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population

NCT00845416

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +8 more
Locations: Chinle Hospital Chinle, Arizona, United States

Tuba City Hospital Tuba City, Arizona, United States

View Trial Details

Completed

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

NCT00220766

Conditions: Agammaglobulinemia, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +24 more
Locations: Departments of Medicine and Microbiology Birmingham, Alabama, United States

National Jewish Medical and Researach Center Denver, Colorado, United States

International Center for Interdisciplinary Studies of Immunology Washington D.C., District of Columbia, United States

Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States

View all 13 locations

View Trial Details

Completed

IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency

NCT00228852

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Repair-Deficiency Disorders, Genetic Diseases, Inborn, +8 more
Locations: Children's Healthcare of Atlanta Atlanta, Georgia, United States

View Trial Details

Severe Combined Immunodeficiency

Severe Combined Immunodeficiency trial results

Related conditions